GB Sciences, Inc. (GBLX)

Market Cap	4.07K
Revenue (ttm)	n/a
Net Income (ttm)	-1.64M
Shares Out	407.07M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,918
Open	0.0081
Previous Close	0.0081
Day's Range	0.0060 - 0.0100
52-Week Range	0.0060 - 0.0100
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About GB Sciences

GB Sciences, Inc., a plant-based research and biopharmaceutical drug development company. The company offers cannabis inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson’s disease, neuropathic pain, chronic pain, cytokine release syndrome, stress/anxiety/depression, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Scie...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: GBLX